Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc. (COEP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · COEP · as of Jun 9, 2026
Key Statistics
Explore Coeptis Therapeutics, Inc. Data
coep stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
coep competitorsCOEP
CUE
EQ
IPSC
KPTI
MDCXStock Performance
Full HistoryAbout Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc. is a biopharmaceutical company dedicated to the advancement and market introduction of both generic and proprietary pharmaceutical products, as well as cell therapy platform…
what is coeptis therapeutics, inc. · coep stock overview · coeptis therapeutics, inc. company profile · who is coeptis therapeutics, inc. ceo · coep NASDAQ · coeptis therapeutics, inc. headquarters · coeptis therapeutics, inc. business segments
About Stock Overview & Key Data
Coeptis Therapeutics, Inc. (COEP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 17, 2020. As of the latest trading session, COEP stock price is $16.40, with a market capitalization of $57.6M. The stock has returned +78.45% over the past 12 months and +15.09% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Coeptis Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Coeptis Therapeutics, Inc. reported revenue of $1.4M and net income of -$11.9M. For detailed data — including Coeptis Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Coeptis Therapeutics, Inc. (COEP) stock price is $16.40. The stock is traded on NASDAQ under the ticker symbol COEP. The 52-week range is $6.80 – $21.41.